<DOC>
	<DOCNO>NCT00003718</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . PURPOSE : Phase II trial study effectiveness temozolomide treat patient advanced soft tissue sarcoma .</brief_summary>
	<brief_title>Temozolomide Treating Patients With Advanced Soft Tissue Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy , measure response rate , temozolomide patient unresectable , stage IV , recurrent soft tissue sarcoma fail 2 prior treatment regimen . II . Determine clinical laboratory toxicity , well patient tolerance , regimen patient population . OUTLINE : Patients stratify accord ECOG performance status ( 0-1 v 2 ) , prior surgery ( yes v ) , prior radiotherapy ( yes v ) , prior chemotherapy regimen ( 0 vs 1 v 2 ) . Patients receive oral temozolomide every 12 hour 5 day . Courses repeat every 4 week least 18 month absence unacceptable toxicity disease progression . Patients follow every 3 month first 18 month , every 6 month next 18 month , annually thereafter death . PROJECTED ACCRUAL : A total 15-25 patient accrue study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically , cytologically , clinically confirm unresectable , stage IV , recurrent soft tissue sarcoma No Ewing 's sarcoma , Kaposi 's sarcoma , bone sarcoma , mesothelioma , primitive neuroectodermal tumor Bidimensionally measurable disease xray , CT scan MRI , physical examination No CNS metastases No 2 prior chemotherapy regimen advance , recurrent , metastatic disease PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Greater 12 week Hematopoietic : Platelet count least 100,000/mm3 Hemoglobin great 10.0 g/dL WBC least 3,500/mm3 OR Absolute neutrophil count least 1,500/mm3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT/SGPT great 1.5 time ULN Alkaline phosphatase less 2 time ULN Renal : Calcium le ULN Creatinine BUN less 1.5 time ULN OR Creatinine clearance great 60 mL/min Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , fully excise and/or treated stage I cancer currently complete remission No nonmalignant systemic disease render patient poor medical risk No acute infection require IV antibiotic HIV negative No AIDSrelated illness No frequent vomit medical condition could interfere oral medication intake ( e.g. , partial bowel obstruction ) PRIOR CONCURRENT THERAPY : Biologic therapy : Prior biologic response modifier treatment allow At least 4 week since prior immunotherapy At least 4 week since prior biologic therapy No concurrent epoetin alfa Chemotherapy : See Disease Characteristics Prior dacarbazine allow At least 4 week since prior chemotherapy No concurrent chemotherapy Endocrine therapy : No concurrent hormonal therapy malignancy Radiotherapy : At least 3 week since prior radiotherapy recover No prior radiotherapy area measurable disease unless clear progression measurable disease outside area prior radiation No concurrent radiotherapy Surgery : At least 4 week since prior surgery recover Other : No concurrent investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2001</verification_date>
	<keyword>adult angiosarcoma</keyword>
	<keyword>adult fibrosarcoma</keyword>
	<keyword>adult leiomyosarcoma</keyword>
	<keyword>adult liposarcoma</keyword>
	<keyword>adult neurofibrosarcoma</keyword>
	<keyword>adult synovial sarcoma</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>adult extraskeletal chondrosarcoma</keyword>
	<keyword>adult alveolar soft-part sarcoma</keyword>
	<keyword>adult epithelioid sarcoma</keyword>
	<keyword>adult malignant fibrous histiocytoma</keyword>
	<keyword>adult malignant hemangiopericytoma</keyword>
	<keyword>adult malignant mesenchymoma</keyword>
	<keyword>adult rhabdomyosarcoma</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>uterine carcinosarcoma</keyword>
	<keyword>uterine leiomyosarcoma</keyword>
	<keyword>endometrial stromal sarcoma</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
</DOC>